艾力斯(688578) - 2026 Q1 - 季度业绩预告

Financial Performance Forecast - The company expects to achieve operating revenue of ¥155,000 million in Q1 2026, an increase of ¥45,163 million, representing a year-over-year growth of 41.12%[3] - The net profit attributable to the parent company is projected to be ¥59,000 million, an increase of ¥17,950 million, reflecting a year-over-year growth of 43.73%[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses is expected to be ¥57,000 million, an increase of ¥17,416 million, with a year-over-year growth of 44.00%[3] - In Q1 2025, the company achieved operating revenue of ¥109,837 million and a net profit of ¥41,050 million[5] Factors Influencing Performance - The growth in performance is attributed to the support and coverage of national medical insurance policies, leading to increased sales revenue from commercialized products and promotional services[7] Earnings Forecast Validity - The financial data provided in the earnings forecast has not been audited by registered accountants[4] - The company has not identified any significant uncertainties that could affect the accuracy of the earnings forecast[9] - The earnings forecast is based on preliminary calculations and professional judgment by the company's finance department[8] Investment Advisory - Investors are advised to pay attention to investment risks as the data is subject to change until the official Q1 2026 report is released[10] - The announcement was made by the board of directors on March 4, 2026[12]